PF-07999415: Tolerance Study in Healthy Adults

We are investigating how well different amounts of the medicine PF-07999415 are tolerated by healthy adults. This study will help us understand its effects in the body.

6-12 monthsSafety phase (I)EndocrinologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Sponsor: Pfizer Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.